- Home
- IRON vs ARDX Comparison
IRON vs ARDX Comparison
Compare IRON & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRON
- ARDX
- Stock Information
- Founded
- IRON 2017
- ARDX 2007
- Country
- IRON United States
- ARDX United States
- Employees
- IRON N/A
- ARDX N/A
- Industry
- IRON Biotechnology: Pharmaceutical Preparations
- ARDX Biotechnology: Pharmaceutical Preparations
- Sector
- IRON Health Care
- ARDX Health Care
- Exchange
- IRON Nasdaq
- ARDX Nasdaq
- Market Cap
- IRON 1.4B
- ARDX 1.2B
- IPO Year
- IRON N/A
- ARDX 2014
- Fundamental
- Price
- IRON $64.03
- ARDX $4.37
- Analyst Decision
- IRON Strong Buy
- ARDX Buy
- Analyst Count
- IRON 10
- ARDX 7
- Target Price
- IRON $73.70
- ARDX $11.75
- AVG Volume (30 Days)
- IRON 253.9K
- ARDX 3.4M
- Earning Date
- IRON 11-12-2024
- ARDX 10-31-2024
- Dividend Yield
- IRON N/A
- ARDX N/A
- EPS Growth
- IRON N/A
- ARDX N/A
- EPS
- IRON N/A
- ARDX N/A
- Revenue
- IRON N/A
- ARDX $251,849,000.00
- Revenue This Year
- IRON N/A
- ARDX $168.07
- Revenue Next Year
- IRON N/A
- ARDX $15.16
- P/E Ratio
- IRON N/A
- ARDX N/A
- Revenue Growth
- IRON N/A
- ARDX 87.57
- 52 Week Low
- IRON $25.60
- ARDX $4.34
- 52 Week High
- IRON $77.60
- ARDX $10.13
- Technical
- Relative Strength Index (RSI)
- IRON 53.08
- ARDX 34.51
- Support Level
- IRON $62.31
- ARDX $5.18
- Resistance Level
- IRON $67.87
- ARDX $5.47
- Average True Range (ATR)
- IRON 3.04
- ARDX 0.32
- MACD
- IRON -0.46
- ARDX -0.07
- Stochastic Oscillator
- IRON 38.78
- ARDX 3.28
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of inventive therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The Company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis.
About ARDX Ardelyx Inc.
Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.